MANAGEMENTUL BOLII PARKINSON - Gr.T. Popa

Survey of German neurologists in private practice. J Neurol, 2009; 256(10): 1681-
1688
20
Jain CK, Vishwanathan N. Parkinson’s disease: A perilous magic of nature.
Scientific Research and Essay 2007; 2(7): 251-255
21
Winter Y, von Campenhausen S, Gasser J, Seppi K, Reese JP, Pfeiffer KP et.
al. Social and clinical determinants of quality of life in Parkinson’s disease in
Austria: a cohort study. J Neurol 2010; 257(4): 638-645
22
Rosenberg JD. Informed consent and sham surgery as a placebo in fetal cell
transplant therapy research for Parkinson’s disease. Einstein J Biol Med 2003; 20:
14-18
23
Weijer C. I need a placebo like I need a hole in the Head. J Law Med Ethics
2002;. 30(1): 69-72
24
Kieburtz K. Benefits of COMT inhibitors in levodopa-treated parkinsonian
patients. Neurology 2000; 55(Suppl. 4): S42-S45
25
Valeikene V, Alenka V, Juozulynas A, Mieliauskaite D, Ceremnych J.
Parkinson’s disease: the most common diagnostic mistakes in Lithuania. Cent Eur J
Med 2009; 4(3): pg. 304-309
26
Băjenaru O, Perju-Dumbravă L, Tiu C, Popescu BO. Ghid de diagnostic şi
tratament în boala Parkinson. Revista Română de Neurologie 2004; 3(2): 79-91
27
Zoukos Y, Thomaides TN, Kidd D, Cuzner ML, Thompson A. Expression of
b2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary
and secondary progressive multiple sclerosis: a longitudinal six month study. J
Neurol Neurosurg Psychiatry 2003; 74(2): 197-202
28
Wolters ECh. Parkinsonims, in Parkinsonism and related disorders. In
Wolters ECh, van Laar T, Berendse HW. Amsterdam: VU University Press; 2007
29
Elble RJ. Origins of tremor. Lancet 2000; 355(9210): 1113-1114
30
Larsen JP, Tandberg E. Sleep disorders in patients with Parkinson’s disease.
Epidemiology and management. CNS Drugs 2001; 15(4): 267-275
31
Poewe W. Continous dopaminergic stimulation in the clinical setting.
Managing patients with advanced Parkinson’s disease. In Aquilonius SM, Lees A.
Managing advanced Parkinson’s disease: the role of continuous dopaminergic
stimulation. London: ScopeMedical Ltd; 2007
32
Deuschl G, Raethjen J, Lindemann M, Krack P. The pathophysiology of
tremor. Muscle Nerve 2001; 24:716-735
33
Bennazzouz A, Pillat B, Ni ZG, Koudsie A, Pollac P, Benabid AL.
Implication of the subthalamic nucleus in the pathophysiology and pathogemesis of
Parkinson’s disease. Cell Transplant 2000; 9(2): 215-221
34
Groenewegen HJ, Dongen YC. Role of the basal ganglia. In Wolters ECh,
van Laar T, Berendse HW. Parkinsonism and related disorders. Amsterdam: VU
University Press; 2007
58